Shire’s Firazyr gains US approval after initial setback
September 1, 2011Sales and Marketing FDA, Firazyr, Shire
After three years of waiting Shire’s Firazyr has been approved by the FDA for sudden attacks of swelling. The US …
Merck acquires cell imaging instrument maker Amnis
September 1, 2011Research and Development Merck KGaA, Millipore
EMD Millipore, the Massachussetts-based life sciences arm of Merck KGaA, has bought US cell imaging instrument maker Amnis Corporation for …
Boehringer expands afatinib breast cancer trials
August 31, 2011Research and Development Boehringer, afatinib
Boehringer Ingelheim has begun two new phase II trials of its investigational cancer drug afatinib. The studies will cover afatinib’s …
FDA wants more information on Novartis arthritis drug
August 31, 2011Sales and Marketing FDA, Ilaris, Novarits, canakinumab
The FDA has asked Novartis for more information on its gouty arthritis drug canakinumab. The regulator’s request came in a …
Pradaxa and Eliquis gain trial boost over warfarin
August 31, 2011Sales and Marketing Eliquis, Pradaxa, Xarelto, apixaban
A pair of new blood thinners are superior to warfarin when it comes to reducing the risk of stroke in …
Nurofen Plus recall expanded
August 31, 2011Sales and Marketing MHRA, Nurofen, recalls
Last week’s recall of Reckitt Benckiser’s painkiller product Nurofen Plus has been expanded after two additional cases emerged where powerful …
FDA approves Pfizer’s lung cancer drug Xalkori
August 30, 2011Sales and Marketing FDA, Pfizer, Xalkori, crizotinib
Pfizer’s lung cancer drug Xalkori has been approved by the FDA, a month ahead of schedule. Xalkori (crizotinib) is now …
Teva in the dock again for hepatitis link to propofol
August 30, 2011Manufacturing and Production Teva, manufacturing and production news, propofol
Teva’s decision to shut down a manufacturing facility for the anaesthetic propofol has become a focal point in a US …
GE gets bigger in upstream bioprocessing with PAA Labs buy
August 30, 2011Manufacturing and Production GE Healthcare, PAA Labs, manufacturing and production news
General Electric unit GE Healthcare has continued to expand its life sciences business with an agreement to buy privately-held PAA …
Catalent to buy Aptuit and claim number two spot in clinical supply
August 30, 2011Manufacturing and Production Aptuit, Catalent, manufacturing and production news
Catalent Pharma Solutions has agreed to purchase the clinical trial supply business of Aptuit in a $410 million deal which …
New electronic submission validation criteria
August 29, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
On Thursday 1st September a new version of the validation criteria for electronic submissions for human medicines will come into …
MSD sways NICE with Simponi patient access scheme
August 26, 2011Sales and Marketing NICE, Simponi, ankylosing spondylitis
A patient access scheme which lowers Simponi’s cost has led to Merck Sharp and Dohme’s drug being given the thumbs …
Boehringer-Lilly’s Trajenta wins European approval
August 26, 2011Sales and Marketing Tradjenta, Trajenta, diabetes
Boehringer Ingelheim and Eli Lilly’s new type II diabetes drug Trajenta has been approved Europe. The European Commission backed Trajenta …
Reckitt painkiller packs may contain antipsychotics, says MHRA
August 26, 2011Manufacturing and Production, Sales and Marketing MHRA, Nurofen, Seroquel, parallel imports
Consumers in the UK are being warned to double-check packs of Reckitt Benckiser’s painkiller product Nurofen Plus following reports that …
Rock adds four new starters
August 26, 2011Medical Communications appointments, medical communications
Rock Medical Communications has appointed four new people to its specialist medical education team. Sam Flynn joins as account manager …
Google fined $500m for online drug advertising
August 26, 2011Medical Communications, Sales and Marketing Google Adwords, counterfeits, google
Google has been fined $500 million by the US government for allowing pharmacies based in Canada to advertise unlicenced drugs …
AkzoNobel appoints new investor relations director
August 25, 2011Sales and Marketing appointment, sales and marketing
Jonathan Atack is set to join AkzoNobel as the company’s new corporate director of investor relations. He was most recently …
Market access and the new NHS in England
August 25, 2011Sales and Marketing NHS, NHS reforms
The National Health Service in England is undergoing massive structural and financial upheaval, and pharma marketers will be rightly concerned …
Sharp increase in NHS diabetes prescribing costs
August 25, 2011Sales and Marketing GP prescribing, NHS, diabetes, prescribing
NHS prescribing for diabetes has risen sharply, largely driven by the disease’s growing prevalence in the UK. Spending rose 41% …
NICE says no to BMS for second-line Orencia
August 25, 2011Sales and Marketing BMS, NICE, Orencia, rheumatoid arthritis
In final draft guidance NICE has not recommended the use of Bristol-Myers Squibb’s arthritis drug Orencia after other drugs have …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
